BAER:SIXJulius Baer Gruppe AG Analysis
Data as of 2026-06-17 - not real-time
$1.84
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Bridger Aerospace Group Holdings (BAER) is trading around $1.84, barely above its 20‑day SMA of $2.02 and well below the 200‑day SMA of $2.04, indicating a price lagging its longer‑term trend. The RSI sits at 43, suggesting neutral momentum, while the MACD histogram remains negative, confirming bearish short‑term pressure and a decreasing volume trend. Fundamentally, the company reports a 45.6% revenue decline, negative operating margins and a book value per share of –$6.61, compounded by a debt‑to‑equity ratio exceeding 730, which signals significant balance‑sheet stress. Despite these challenges, analyst coverage from Lake Street initiated a Buy rating with an average one‑year price target of $4.00, implying over 120% upside and aligning with the extreme greed sentiment (92.6) in the market. Volatility is exceptionally high at over 100% on a 30‑day basis, and the beta of roughly 1.9 points to amplified moves relative to the market, while the max drawdown of nearly 49% underscores historical price fragility. The stock’s liquidity is constrained, with decreasing volume and a modest market cap of $106 M, raising concerns about execution risk. Overall, the juxtaposition of a deeply discounted market price against lofty analyst targets creates a speculative play that hinges on the company securing new firefighting contracts and improving cash flow, while the heavy debt load and negative equity remain fundamental headwinds.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and decreasing volume
- Neutral RSI and price below short‑term SMA
- Recent analyst Buy initiation adds upside potential
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst price targets suggest >120% upside
- Potential contract growth in wildfire suppression services
- Current price offers significant discount to target levels
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt load and negative book value limit upside
- Volatile earnings and cash flow generation
- Strategic positioning in a niche, high‑demand sector
Key Metrics & Analysis
Financial Health
Revenue Growth-45.60%
Profit Margin-10.05%
ROE-31.62%
ROA0.09%
Debt/Equity738.03
P/B Ratio-0.3
Op. Cash Flow$13.3M
Free Cash Flow$-61242000
Industry P/E31.2
Technical Analysis
TrendNeutral
RSI43.3
Support$1.66
Resistance$2.61
MA 20$2.02
MA 50$2.01
MA 200$2.04
MACDBearish
VolumeDecreasing
Fear & Greed Index92.61
Valuation
Target Price$4.12
Upside/Downside123.73%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.92
Volatility101.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.